Eli Lilly shares the increase in the new data of the obesity pill. What means for the actions of here
Eli Lilly is pressing the lucrative weight loss market as it advances to a new and more convenient phase that…
investment strategy
Abbott Labs shares an increase in profits and a great sign of confidence in the business
ABBOTT Laboratories actions jumped on Wednesday after the diversified medical care company delivered strong results of the first quarter and…
Goldman Sachs (GS) Q1 2025 gains
David Solomon, CEO of Goldman Sachs, testifies during an audience of the Senate Banking Committee in the Hart Senate Office…
Jamie Dimon expects S&P 500 profits estimates to fall in the midst of uncertainty
The CEO and president of JPMorgan Chase, Jamie Dimon, makes a gesture while speaking during the Supervision Hearing of the…
Apple recovers with the market, the analyst divided into our drug stock
Every day of the week, the CNBC Investing Club with Jim Cramer has a live broadcast of the “morning meeting”…
We are leaving our position in a medical care action to raise some cash.
Shortly after the opening bell, we will leave our position in Ge Healthcare, selling 550 shares at approximately $ 65.…
Trump tariffs will challenge the big pharmaceuticals. Here are well positioned actions
Long Data Commercial Agreements have greatly protected the pharmaceutical industry of tariffs, but the objective of President Donald Trump to…
Do not ignore the impact of pharmaceutical rates, says an analyst. Where we stop in Bristol Myers
The drug stock is higher during the past month, while the S&P 500 has retired sharply.
We are buying more shares of 2 shares as the broader market sinks more
We are doing our first exchanges of the week. We are buying 25 shares from Danaher to approximately $ 207…
Life sciences are under pressure due to possible NIH funds cuts
A recent Trump administration movement to substantially reduce the funds of the National Health Institutes for research institutions throughout the…